Atlas market file ¡ Etf ¡ United States
VictoryShares US EQ Income Enhanced Volatility Wtd ETFCDC
- Last close
- 76.4738
- Change
- +0.29%
- 96-bar range
- 69.65 â 78.48
- As of
- 7 Aug 2026
VictoryShares US EQ Income Enhanced Volatility Wtd ETF is an exchange-traded fund listed as CDC on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 104 weekly closes (+20.98% over the window).
Source rail: Yahoo Finance chart API (CDC). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for CDC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CDC public profile
Exchange-traded fund. VictoryShares US EQ Income Enhanced Volatility Wtd ETF is connected to current market context, cited company sources and its retained research file.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF trades as CDC on NASDAQ. VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CDC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for VictoryShares US EQ Income Enhanced Volatility Wtd ETF today
The VictoryShares US EQ Income Enhanced Volatility Wtd ETF, ticker CDC, is a rules-based equity-income wrapper that weights its 110 US holdings by trailing volatility. The fundâs mandate is straightforward: screen the broad US equity universe, select the top third of names by trailing volatility, and then harvest dividends while the volatility screen is in vogue. The issuer markets this as âincome enhanced by volatility weightingâ, but the reality is closer to âincome plus a fee plus a mechanical tiltâ. The fundâs fact sheet does not promise which companies will land in the portfolio next quarter, only that the selection is volatility-weighted. That leaves investors exposed to both the income whims of the screen and the fundâs 0.45% annual charge.
The fundâs top holdings offer a snapshot of this mechanical approach. Recent filings show Verizon Communications Inc. (VZ) perched at the top, followed by names like Nordstrom Inc. (JWN) and Carrier Global Corp. (CARR). The list is a mixed bag of dividend stalwarts and volatility outliers, which means the âincome enhancedâ label is less a promise and more a rolling outcome of the volatility screen. The issuerâs marketing leans on the theme of volatility-weighted income, but the portfolio itself is a ruleset applied to a broad US equity universe-nothing more, nothing less.
The fundâs prospectus and SEC filings confirm the 0.45% expense ratio and the volatility-weighted selection method. The fundâs page on Nasdaq shows daily volume that can swing from modest to thin, signalling that while the wrapper is open every market day, liquidity is not guaranteed. The SEC EDGAR search confirms the fundâs identity, mandate, and fee structure, but it does not reveal the next quarterâs holdings or the dividend trajectory of the chosen names. The fact sheet promises âenhanced incomeâ, yet the only certainty is the fee.
What CDC actually tracks is a quarterly-rebalanced basket of 110 US equities, selected by trailing volatility and then screened for dividend eligibility. The fundâs tracking method is mechanical, not predictive. The issuerâs marketing promises a smoother income ride, but the portfolio is subject to the whims of volatility and the dividend policies of the underlying companies. The fundâs page on Nasdaq provides market data such as volume and price, but it does not offer forward-looking dividend forecasts or volatility projections. The evidence does not include any named earnings releases, revenue figures, or forward guidance for the underlying holdings, which means the fundâs income claims remain a rolling bet on the screen and the market.
The fundâs liquidity profile is visible on Nasdaq, but the daily volume figures are not guaranteed to deepen. The fundâs expense ratio is fixed at 0.45%, and the volatility-weighted selection method is disclosed in filings, but the actual holdings and their dividend outcomes are not predicted by the evidence. The fundâs mandate and fee are clear; the income outcome is not. The issuerâs marketing promises âenhanced incomeâ, but the portfolioâs income is a function of the volatility screen and the dividend policies of the underlying companies, neither of which are guaranteed.
Sources & evidence ¡ 4 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CDC technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CDC
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CDC research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CDC FAQ
What is VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC)?VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. Use this page to check the price chart,...
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CDC?VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. It brings the latest available chart,...
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CDC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CDC page updated?The CDC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CDC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CDC?The CDC file starts with Nasdaq Trader and TradingView NASDAQ:CDC. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CDC file starts with Nasdaq Trader and TradingView NASDAQ:CDC. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CDC?Yes. The workstation can open CDC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CDC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CDC page investment advice?No. The CDC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CDC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
CDC
Etf ¡ evidence first